SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-20-130001
Filing Date
2020-11-27
Accepted
2020-11-27 16:02:18
Documents
2
Group Members
JEREMY C. GREENREDCO I, L.P.REDMILE CAPITAL FUND, L.P.REDMILE CAPITAL OFFSHORE II MASTER FUND, LTD.REDMILE PRIVATE INVESTMENTS I, L.P.REDMILE STRATEGIC MASTER FUND, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2037154d1_sc13d.htm SC 13D 189711
2 EXHIBIT 99.1 tm2037154d1_ex99-1.htm EX-99.1 11783
  Complete submission text file 0001104659-20-130001.txt   203568
Mailing Address 6665 MILLCREEK DR UNIT 1 MISSISSAUGA A6 L5N 5M4
Business Address 6665 MILLCREEK DR UNIT 1 MISSISSAUGA A6 L5N 5M4 973-509-0444
MedAvail Holdings, Inc. (Subject) CIK: 0001402479 (see all company filings)

IRS No.: 900772394 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86120 | Film No.: 201355310
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D